|
|
|
To download conference scientific program as PDF file click here |
|
|
Thursday
Friday
Saturday
Sunday |
|
|
Thursday, February 24th, 2011
|
|
| 14:00 – 18:00 |
Registration
|
| 17:00 – 18:00 |
Opening Ceremony
|
| 20:00 – 21:30 |
Get Together
|
| Back to top |
|
|
Friday, February 25th, 2011
|
|
| 08:00 – 17:30 |
Registration
|
| 08:30 – 10:30 |
Opening Plenary Session
Chairs: Herman Haller, Reuven Zimlichman |
| 08:30 |
Greetings
Herman Haller, Reuven Zimlichman, Bruno Watschinger
|
|
08:40
|
Prehypertension – History, Definition and Epidemiology
Speaker: Stevo Julius
|
|
|
|
09:10
|
Pathophysiological and Clinical Consequences of Prehypertension
Speaker: Daniel A. Duprez
|
|
|
|
09:30
|
Is it Justified to Merge Normal and High Normal Blood Pressure Into Prehypertension?
Speaker: Robert Fagard |
|
|
|
09:50
|
Debate: Prehypertension – Is it a Disease or Disease Invention?
Pro / Con
Speakers: Stevo Julius / Herman Haller
|
|
|
|
10:10
|
Panel Discussion
Daniel A. Duprez, Herman Haller, Robert Fagard, Stevo Julius , Reuven Zimlichman |
| 10:30 – 11:00 |
Coffee Break
|
| 11:00 – 13:00 |
Plenary Session: Prehypertension and The Cardio Metabolic Syndrome
Chairs: Daniel A. Duprez, Basil S. Lewis |
|
11:00
|
Obesity and Prehypertension
Speaker: TBA |
|
11:20
|
Diabetes and Insulin Resistance in Prehypertension
Speaker: Adam Whaley-Connell |
|
11:40
|
Subclinical Coronary Atherosclerosis defined as Coronary Artery Calcification is associated with Prehypertension and Outcome Results of the Heinz Nixdorf Recall Study
Speaker: Raimund Erbel |
|
12:00
|
Translational pre-clinical analysis of Non-Alcoholic Fatty Liver Disease for the Metabolic Syndrome by non-invasive in-vivo Magnetic Resonance Spectroscop
Speaker: Oliver Steinbach
|
|
12:20
|
Pre-hypertension: Clinical Characteristics and Long-Term Outcome in the Real World
Speaker: Giuseppe Ambrosio |
|
12:40
|
Metabolic and Vascular Effects of Exercise in Metabolicly Compromised Patients
Speaker: Thomas Wascher |
| 13:00 – 14:00 |
Lunch
|
| 14:00 - 15:30 |
Free Communications: Prehypertension and the Cardio Metabolic Syndrome |
|
Plasma Adiponectin, but not Asymmetric Dimethylarginine (ADMA) Level is Associated with Insulin Resistance in Normotensive Offspring of Subjects with Essential Hypertension
Bogomir Zizek |
|
In Germany Fifty Percent Of Male Primary Care Patients Aged 18 to 99 Years Presented With Elevated Blood Pressures In The Prehypertensive State: The German Metabolic and Cardiovascular Risk Study (GEMCAS)
Chakrapani Balijepalli |
|
Clinical Significance of Diagnosis of Prehypertensive Patients with Primary Aldosteronism
Fumitoshi Satoh |
|
Interaction Between Cigarette Smoking and CYP2A6 Genotypes on Prehypertension and Hypertension in Chinese People
Tao Liu |
|
"10annidivitainpi" (a life ten years longer): A Patient Pherapeutic Education for Hypertensive Patients. State of Art
Daniela Scala |
|
Increased Platelet Activation In Young Patients With Prehypertension
Turgay Celik |
|
Garlic, Chocolate or Tomatoes for Prehypertension?
Karin Ried |
|
Blood Pressure Load, Proteinuria and Renal Function in Pre-Hypertensive Children Riccardo Lubrano |
|
Plasmatic Insulin Regulated Aminopeptidase Activity in Type 2 Diabetes Mellitus
Isabel Prieto |
| 15:30 - 16:00 |
Coffee Break |
| 16:00 – 18:00 |
Plenary Session: Pathophysiology of Prehypertension
Chairs: Charalambos Vlachopoulos, Bruno Watschinger |
|
16:00
|
Vascular Aspects (Macrovascular and Microvascular)
Speaker: Charalambos Vlachopoulos |
|
16:20
|
Relationship Between Arterial Function and the Heart
Speaker: Thomas Weber |
|
16:40
|
The Kidney (Early Markers, Progress to Disease)
Speaker: Peter W. de Leeuw |
|
17:00
|
Chronic kidney disease and prehypertension
Speaker: Luis M. Ruilope |
|
17:20
|
Microalbuminuria, as a Feature of "Pre"-Organ Damage
Speaker: Bruno Watschinger |
|
17:40
|
Systolic, Diastolic and Pulse Pressure Monitoring
Speaker: Petr Kala |
| Back to top |
|
|
Saturday, February 26th, 2011
|
|
| 08:00 – 17:30 |
Registration |
| 08:30 – 10:30 |
Satellite Symposium: Arterial Properties in Prehypertension
Chairs: John R. Cockcroft, Ian Wilkinson |
|
08:30
|
Premature Vascular Ageing
Speaker: John R. Cockcroft |
|
09:00
|
Assessment of Arterial Stiffness in Clinical Practice
Speaker: Ian Wilkinson
|
|
09:30
|
Pre-Hypertension and Cardiovascular Haemodynamics in Young Individuals: The ENIGMA Study
Speaker: Carmel McEniery |
|
10:00
|
Panel Discussion
John R. Cockcroft, Carmel McEniery,
Ian Wilkinson, Charalambos Vlachopoulos |
| 10:30 – 11:00 |
Coffee Break |
| 11:00 – 13:00 |
Plenary Session: Cardiovascular Consequences of Prehypertension
Chairs: Sverre E. Kjeldsen, Peter W. de Leeuw |
|
11:00
|
Arterial Plasma Catecholamines Predict Increased Blood Pressure, Weight Gain and Glucose Intolerance after 18 years in Borderline Hypertensive Young Men
Speaker: Sverre E. Kjeldsen
|
|
11:20
|
Cardiac and Vascular Damage in Prehypertnsion
Speaker: Enrico Agabiti Rosei |
|
11:40
|
Prehypertension and (Pre)-Chronic Kidney Disease (CKD) – Fact or Fiction?
Speaker: Alexander Rosenkranz
|
|
12:00
|
Primary Aldosteronism in Prehypertensive and Stage I Hypertensive Patients
Speaker: Gian Paolo Rossi |
|
12:20
|
Panel Discussion: Evaluation and Approach of the Prehypertensive Patients
Sverre E. Kjeldsen, Alexander Rosenkranz,
Gian Paolo Rossi, Enrico Agabiti Rosei |
| 13:00 – 14:00 |
Lunch
|
| 14:00 – 16:00 |
Plenary Session: Clinical Trials in Prehypertension
Chairs: Daniel A. Duprez, Csaba Farsang |
|
14:00
|
Lessons From the TROPHY Trial
Speaker: Stevo Julius |
|
14:20
|
Lessons From Additional Trials (CHIMON, PHARAO and STRONG HEART)
Speaker: Yuging Zhang |
|
14:40
|
Is Regression From Hypertension to Prehypertension Feasible? The Rationale and Design of The STAR CAST Study
Hiroyuki Sasamura |
|
15:00
|
Panel Discussion: Recommendations for Future Trials – What is Needed?
Stevo Julius Daniel A. Duprez, Csaba Farsang,
Yuging Zhang, Hiroyuki Sasamura |
| 15:15 – 15:45 |
Coffee Break |
| 15:45 – 17:00 |
Free Communications: The Arteries and Prehypertension |
|
Associations of Plasma Homocysteine Levels with Arterial Stiffness in Prehypertensive Individuals
Byung Jin Kim |
|
Segmental Aortic Stiffness Measured by MRI and its Effect on Cardiovascular Risk Assessment in Patients with Abdominal Aortic Aneurysm (AAA)
Abeera Abbas |
|
Relationship Between Arterial Stiffness and Increase of Blood Pressure During Exercise in Normotensive Persons
Jidong Sung |
|
Orlistat-Induced Weight Loss Improves Resistance Vessel Smooth Muscle but not Endothelium-Dependent Function in Obese Hypertensive Human Subjects
William Haynes |
|
Prehypertension and Carotid Intima-media Thickness in a Healthy population - Results of the Heinz Nixdorf Recall Study
Marcus Bauer |
|
A Novel Marker of Hypertensive Vascular Lesions : D-ROMs Test and BAP Test as A Marker of Oxidative Stress
Minoru Yamakado
|
|
Early Autonomic Cardiovascular Dysregulation in Young Healthy Adults with Positive Family History for Increased Cardiovascular Risk
Nina Belova |
| 17:00 – 18:15 |
Plenary Session: Non Pharmacologic Approach to Prehypertension
Chairs: Talma Rosenthal , Rudolf de Chatel |
|
Lifestyle Change in Prehypertension (Changing Way of Life)
Speaker: Talma Rosenthal |
|
Overview on smoking and prehypertension
Speaker: Rudolf de Chatel |
|
Tomato Lycopene and Other Phytonutriens for the Prevention of Metabolic Syndrome
Speaker: Ester Paran |
|
Panel Discussion: The Role and Place of Non Pharmacological Approach in Prehypertension
Talma Rosenthal, Rudolf de Chatel, Ester Paran |
|
|
|
|
| Back to top |
|
|
Sunday, February 27th, 2011
|
| 08:00 – 12:00 |
Registration |
| 08:30 – 10:15 |
Plenary Session: Pharmacological Therapy of Prehypertension
Chairs: Thomas Unger , Federico Mayor |
|
08:30
|
Prehypertension and hypertension: a case for OTC-drugs
Speaker: Thomas Unger |
|
08:50
|
The "Polypill" – Should it be Considered in Prehypertension?
Speaker: Sandeep Gupta |
|
09:10
|
Shall We Give Antihypertensive Drugs to a Patient with High Normal Blood Pressure?
Speaker: Csaba Farsang |
|
09:30
|
Adverse Metabolic Consequences of Antihypertensive Drug Treatment
Speaker: Guntram Schernthaner |
|
09:50
|
Panel Discussion |
|
|
| 10:15 – 10:45 |
Coffee Break |
| 10:45 – 12:30 |
Plenary Session: Conclusions and Future Perspectives and Recommendations
Chairs: Daniel A. Duprez , Herman Haller |
|
10:45
|
Prehypertension - Is it a Disease and Should it be Treated?
speakers: Reuven Zimlichman |
|
11:15
|
The Therapeutic Approach - Non Pharmacological and Pharmacological – Recommendations
Speaker: Stevo Julius |
|
11:45
|
Prehypertension Guidelines
Chair, Panel Discussion and Audience
Daniel A. Duprez , Herman Haller, Basil S. Lewis, Reuven Zimlichman |
|
12:15
|
Conference Closure |
| Back to top |
|
|
Prehypertension and Cardio Metabolic Syndrome International Conference Secretariat 